Clinical Trials
35 trialsThe Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC
The First Affiliated Hospital of Dalian Medical University
MK-3475-E90
Wellmarker Bio
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
CAT_PB
Lebanese University
Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Avistone Biotechnology Co., Ltd.
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer
Fox Chase Cancer Center
Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status
Guangzhou Institute of Respiratory Disease
Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer
Qianfoshan Hospital
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
MICROBIOME
Imperial College London
A Clinical Trial of TAA06 Injection in Advanced Solid Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Massachusetts General Hospital
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Awake Thoracic Epidural Anaesthesia Versus General Anesthesia for Video Assisted Thoracoscopic Surgery
Assiut University
Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer
Shenzhen People's Hospital
COTI2-101
Critical Outcome Technologies Inc.
NY-ESO-1 TCR (TAEST16001)for Patients With Advanced NSCLC
Guangzhou Institute of Respiratory Disease
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
Biocad
First-line Combination Treatment Based on Anlotinib
Shanghai Chest Hospital
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Southwest Hospital, China
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
CURCUMIN
Lady Davis Institute
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
Alliancells-PuRui Biocience Co., Ltd.
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
National Cancer Institute (NCI)
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
National Cancer Institute (NCI)
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Copharos